Metabolism of Equilenin in MCF-7 and MDA-MB-231 Human Breast Cancer Cells
Authors:
- 19 April 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 14 (5) , 572-581
Abstract
Sulfate conjugates of the B-ring unsaturated estrogens, equilin, equilenin, and 8-dehydroestrone, and their 17α- and 17β-dihydro analogues, constitute about 54% of Premarin (Wyeth-Ayerst), the most commonly prescribed estrogen formulation in estrogen replacement therapy. Despite the wide clinical use of Premarin, there have been very few studies on the metabolism of the B-ring unsaturated estrogens in humans and there is no information regarding the fate of these compounds in breast tissue or tumors. In this study, we investigated the metabolism of equilenin in two lines of human breast-cancer cells, MCF-7 and MDA-MB-231. MCF-7 cells respond to treatment with Ah-receptor agonists with induction of cytochromes P450 1A1 and 1B1, whereas in MDA-MB-231 cells P450 1B1 is predominantly induced. Metabolites of equilenin were identified and quantified by GC/MS utilizing a series of synthetic metabolite standards and deuterium-labeled analogues as internal standards. In the two cell lines, the same pathways of equilenin metabolism were observed. Equilenin was reduced at C-17 to the 17β-dihydro form, with minimal production of the 17α-dihydro isomer. Both equilenin and 17β-dihydroequilenin were hydroxylated at the C-4 position, and the resultant catechol metabolites were methylated to form 4-methoxyequilenin and 4-methoxy-17β-dihydroequilenin. Rates of equilenin metabolism were markedly elevated in cultures exposed to the Ah-receptor agonists, 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,4,4‘,5-tetrachlorobiphenyl, implicating the activities of P450s 1A1 and 1B1 in the metabolism. The 2-hydroxylation pathways of equilenin and 17β-dihydroequilenin metabolism were not observed. In microsomal reactions with cDNA-expressed human enzymes, both P450s 1A1 and 1B1 catalyzed the 4-hydroxylation of 17β-dihydroequilenin, whereas with 17β-estradiol as substrate P450 1A1 catalyzes predominantly 2-hydroxylation and P450 1B1 predominantly 4-hydroxylation. Since P450 1B1 is constitutively expressed and both P450s 1A1 and 1B1 are inducible in many extrahepatic tissues including the mammary epithelium, these results indicate the potential for 4-hydroxylation of equilenin and 17β-dihydroequilenin in extrahepatic, estrogen-responsive tissues.Keywords
This publication has 13 references indexed in Scilit:
- Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1Biochemical Pharmacology, 1999
- 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cellsJournal of Cellular Biochemistry, 1998
- Relationship Between Estrogen Levels, Use of Hormone Replacement Therapy, and Breast CancerJNCI: Journal of the National Cancer Institute, 1998
- Pharmacokinetics and Pharmacodynamics of Conjugated Equine Estrogens: Chemistry and MetabolismExperimental Biology and Medicine, 1998
- Postmenopausal Hormone Therapy and MortalityNew England Journal of Medicine, 1997
- The effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17β-estradiol 4-hydroxylaseThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: A comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNAArchives of Biochemistry and Biophysics, 1992
- The Saga of the Ring B Unsaturated Equine Estrogens*Endocrine Reviews, 1988
- Carcinogenicity of catechol estrogens in Syrian hamstersJournal of Steroid Biochemistry, 1986
- Relative rates of 2‐ and 4‐hydroxyestrogen synthesis are dependent on both substrate and tissueFEBS Letters, 1982